Natera Says Rival Infringes Cancer Testing Patents
Genetic testing company Natera Inc. has accused a rival lab of infringing its patents for a DNA test to detect and manage cancer, according to a complaint filed in North Carolina...To view the full article, register now.
Already a subscriber? Click here to view full article